| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |